by In2Pharma | Jul 5, 2022 | News
Europe All Marketing authorisation holders (MAHs) should register their Industry Single Point of Contact (i-SPOC) who will inform EMA about the supply and availability of critical medicines identified in the context of a ‘public health emergency’ or a ‘major event’...
by In2Pharma | Jul 5, 2022 | News
Europe The Commission Regulation (EU) 2022/860 amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards monacolins from red yeast rice has been published on 2nd June 2022. This Regulation entered into force on 22nd...
by In2Pharma | Jul 5, 2022 | News
Belgium On 4th of July 2022, the FAMHP launches the Medicinal Product Management database, a new internal database for medicinal products. Due to the launch of the new database, existing databases will temporarily not be updated. As from 22nd June data will be...
by In2Pharma | Jun 22, 2022 | News
Belgium The Vigilance Division of the FAMHP requests marketing authorisation holders to send the approved version of the risk management plan for medicinal products for human use with a national marketing authorisation.In order to have a better overview of the...
by In2Pharma | Jun 21, 2022 | News
Belgium We remind you that the honorary indexation of the Pharmacy distribution price in Belgium has an impact on the prices and this difference must be URGENTLY communicated to the Ministry of Social Security. Indeed, the Luxembourgish law imposes that the price of...
